Insider Transactions in Q3 2021 at Translate Bio, Inc. (TBIO)
Insider Transaction List (Q3 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 14
2021
|
Jean Francois Formela Director |
SELL
Open market or private sale
|
Indirect |
2,055,063
-100.0%
|
$78,092,394
$38.0 P/Share
|
|
Sep 14
2021
|
Owen Hughes Director |
SELL
Open market or private sale
|
Direct |
29,860
-100.0%
|
$1,134,680
$38.0 P/Share
|
|
Sep 14
2021
|
Paul D. Burgess Chief Operating Officer, CLO |
SELL
Open market or private sale
|
Direct |
71,833
-100.0%
|
$2,729,654
$38.0 P/Share
|
|
Sep 14
2021
|
Ronald C Renaud Jr Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
450,822
-100.0%
|
$17,131,236
$38.0 P/Share
|
|
Sep 14
2021
|
Ronald C Renaud Jr Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
503,231
-100.0%
|
$19,122,778
$38.0 P/Share
|
|
Sep 14
2021
|
Sanofi > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
71,983,597
+34.8%
|
$2,735,376,686
$38.0 P/Share
|